A Patient Story In The UK
March 8, 2023
Libmeldy gene therapy is used for the first time in the UK outside of a clinical trial
2 min read
February 2023
Flu is a key focus in this issue; we ask experts if it's time for influenza vaccine manufacturing to move away from eggs and to instead embrace newer approaches. In In My View, experts give their opinions on the realities of mRNA therapeutic storage, and how digital health technology can help clinical trials be more accessible. Also in this issue, we find out what the energy crisis in Europe means for pharma, why no one wants a "Where's Waldo" situation in clinical trials, and how manufacturing tech is advancing for cell therapy manufacturing. We finish up by sitting down with Eric Dube, CEO of Travere Therapeutics.
Flu Season: March of the mAbs
February 15, 2023
As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments
3 min read
Connected Patient-Centricity
February 7, 2023
How digital health technology can help clinical trials be more inclusive and accessible
5 min read
The Blood Clot and the Invisible Frog
February 3, 2023
Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators
2 min read
Winter is Coming: How the Energy Crisis Will Change Pharma in 2023
January 10, 2023
In the face of war and the lingering economic aftereffects of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?
6 min read
Cell and Gene: Generating the Next Generation
January 9, 2023
Thousands of cell and gene therapy trials are underway, so, assuming at least some success, what can the field do to avoid a seemingly inevitable rush on supporting products and services?
4 min read
A Tale of Two Inhibitors
January 6, 2023
Two drugs, two different destinies. Does their story prove that business practice makes the difference?
4 min read
A Day in Egg City: Seven Things I Learned on a Visit to Britain’s Largest Flu Vaccine Factory
December 16, 2022
From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect
8 min read
Cell and Ex Vivo Gene Therapies: A Manufacturing Odyssey
December 5, 2022
Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task? Technology companies are on the case and new solutions are emerging. Here, we explore the key considerations when developing ex vivo gene therapy and cell therapy processes for commercial manufacturing.
17 min read
Chill Out: Understanding the Realities of mRNA Therapeutic Storage
August 3, 2022
Are glass syringes suitable options for mRNA therapeutics application?
4 min read
Teaching Old Drugs New Tricks
June 29, 2015
Could existing drugs be repurposed as a shortcut to treating Ebola?
1 min read
